Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites

BACKGROUND: Recent circumstantial evidence suggests that an increasing number of Iranian patients with cutaneous leishmaniasis are unresponsive to meglumine antimoniate (Glucantime), the first line of treatment in Iran. This study was designed to determine whether the clinical responses (healing, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadighi, Ramtin, Mohebali, Mehdi, Boucher, Patrick, Hajjaran, Homa, Khamesipour, Ali, Ouellette, Marc
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435779/
https://www.ncbi.nlm.nih.gov/pubmed/16605301
http://dx.doi.org/10.1371/journal.pmed.0030162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435779/
https://www.ncbi.nlm.nih.gov/pubmed/16605301
http://dx.doi.org/10.1371/journal.pmed.0030162

Ejemplares similares